Castle Biosciences Inc (CSTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 85,572 | 82,949 | 98,841 | 91,223 | 95,874 |
| Marketable Securities | 174,116 | 156,264 | 144,258 | 138,530 | 129,634 |
| Receivables | 45,988 | 42,699 | 38,302 | 37,003 | 31,314 |
| Inventories | 8,013 | 7,645 | 7,942 | 5,769 | 6,121 |
| TOTAL | $320,405 | $295,778 | $295,635 | $279,622 | $269,054 |
| Non-Current Assets | |||||
| PPE Net | 38,638 | 32,904 | 25,433 | 22,273 | 20,511 |
| Other Non-Current Assets | 128,269 | 129,825 | 132,272 | 134,124 | 135,835 |
| TOTAL | $166,907 | $162,729 | $157,705 | $156,397 | $156,346 |
| Total Assets | $487,312 | $458,507 | $453,340 | $436,019 | $425,400 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,540 | 9,318 | 10,268 | 6,929 | 7,135 |
| Accrued Expenses | 21,239 | 14,708 | 28,945 | 22,405 | 17,298 |
| TOTAL | $39,454 | $31,959 | $47,667 | $36,324 | $33,717 |
| Non-Current Liabilities | |||||
| Long Term Debt | 10,008 | 10,000 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 13,645 | 13,880 | 14,198 | 13,471 | 12,474 |
| TOTAL | $23,965 | $24,086 | $14,404 | $13,912 | $12,915 |
| Total Liabilities | $63,419 | $56,045 | $62,071 | $50,236 | $46,632 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 27,737 | 27,607 | 27,450 | 26,911 | 26,810 |
| Common Shares | 28 | 28 | 27 | 27 | 27 |
| Retained earnings | -211,985 | -220,905 | -218,371 | -215,791 | -208,886 |
| Other shareholders' equity | -172 | -111 | 136 | -71 | -144 |
| TOTAL | $423,893 | $402,462 | $391,269 | $385,783 | $378,768 |
| Total Liabilities And Equity | $487,312 | $458,507 | $453,340 | $436,019 | $425,400 |